296 In the index

PF-06260414 PF-06

An early experimental muscle-building compound from a major drug company's research pipeline, studied only in animals. There's no published human trial data, consistent with a compound that didn't make it past early development.

Also known as PF06260414

Effects Build muscle

Routes Oral

Legal status Research chemical

WADA Banned at all times

3D Molecular Structure of C₁₄H₁₄N₄O₂S

Drag to rotate · scroll to zoom

Chemistry

Formula: C14H14N4O2S
Molar mass: 302.35
CAS: 1612755-71-1
PubChem CID: 76071881

Reported dosing

Clinical data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Not established (development discontinued)

Reported range Early trial doses not widely published

Route Subcutaneous injection

Frequency Not established

Duration Not established

An investigational Pfizer GLP-1 receptor agonist peptide whose development was discontinued after injection-site reactions in trials; no approved product exists.

Where this comes from Discontinued early-phase clinical trial data (Pfizer)

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.